Lv2
140 积分 2024-10-28 加入
Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody–Drug conjugates
1个月前
已关闭
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
3个月前
已完结
Peri-operative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small cell lung cancer: final analysis of the randomized RATIONALE-315 trial
4个月前
已完结
Cancer pain experiences in adult patients with cancer: A qualitative meta-ethnography
4个月前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
5个月前
已关闭
Rethinking Survival Metrics in EGFR-Mutated NSCLC: Insights from RMST Analysis of FLAURA2 and MARIPOSA
5个月前
已关闭
Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study
5个月前
已完结
Current Controversies and Challenges in Non–Oncogene-Addicted Synchronous Oligometastatic Non–Small Cell Lung Cancer
6个月前
已完结
Echoes of the Past: Radiation Recall Pneumonitis Following Extrapulmonary Radiation Therapy
6个月前
已完结
皖公网安备34019202002308
